Silvio Paolo Mariotti
Overview
Explore the profile of Silvio Paolo Mariotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amore F, Silvestri V, Turco S, Fortini S, Giudiceandrea A, Cruciani F, et al.
BMC Health Serv Res
. 2024 Nov;
24(1):1323.
PMID: 39482692
Background: Research and monitoring of human resources available for vision rehabilitation services has been a neglected area of work in the past. This study aims to offer an overview of...
2.
Fortini S, Costanzo E, Rellini E, Amore F, Mariotti S, Varano M, et al.
BMJ Open
. 2024 Jan;
14(1):e075141.
PMID: 38238181
Objectives: The aim of this study was to evaluate the influence of anxiety and depression on clinician decision-making in patients suffering from chronic eye disease in ophthalmological clinical practice. Design...
3.
The Effect of Varied Microperimetric Biofeedback Training in Central Vision Loss: A Randomized Trial
Silvestri V, De Rossi F, Piscopo P, Perna F, Mastropasqua L, Turco S, et al.
Optom Vis Sci
. 2023 Sep;
100(11):737-744.
PMID: 37747894
Significance: This investigation reports for the first time the effects of different microperimetric biofeedback strategies in visually impaired subjects with central field loss. Purpose: This study aimed to evaluate the...
4.
Virgili G, Parravano M, Petri D, Maurutto E, Menchini F, Lanzetta P, et al.
J Clin Med
. 2022 May;
11(9).
PMID: 35566537
We conducted a systematic review and meta-analysis to investigate whether depression is associated with vision impairment (VI) in population-based studies in adults. MEDLINE and EMBASE were searched, from inception to...
5.
Amuthavalli Thiyagarajan J, Araujo de Carvalho I, Pena-Rosas J, Chadha S, Mariotti S, Dua T, et al.
PLoS Med
. 2019 Oct;
16(10):e1002948.
PMID: 31626651
Islene Araujo de Carvalho and coauthors discuss the WHO guidelines on integrated care for older people.
6.
Zhao J, Mariotti S, Resnikoff S, Wang Y, Yu S, He M, et al.
PLoS Negl Trop Dis
. 2019 Jun;
13(6):e0007531.
PMID: 31233511
[This corrects the article DOI: 10.1371/journal.pntd.0007130.].
7.
Zhao J, Mariotti S, Resnikoff S, Wang Y, Yu S, He M, et al.
PLoS Negl Trop Dis
. 2019 Jan;
13(1):e0007130.
PMID: 30689647
Background: China used to be among the countries with a high prevalence of trachoma. At the launch of The Global Elimination of Trachoma (GET) 2020 campaign by the World Health...
8.
Katibeh M, Kalantarion M, Mariotti S, Safi S, Shahraz S, Kallestrup P, et al.
Arch Iran Med
. 2017 May;
20(5):288-294.
PMID: 28510464
Objective: To assess the national health system for management of diabetes mellitus (DM) in Iran, with particular focus on diabetic retinopathy (DR). Materials And Methods: In this qualitative study, the...
9.
Pascolini D, Mariotti S
Br J Ophthalmol
. 2011 Dec;
96(5):614-8.
PMID: 22133988
Aim: From the most recent data the magnitude of visual impairment and its causes in 2010 have been estimated, globally and by WHO region. The definitions of visual impairment are...
10.
Madani M, Huguet P, Mariotti S, Dezoumbe D, Tosi C, Djada D, et al.
Sante
. 2003 Aug;
13(1):9-15.
PMID: 12925317
A regional survey was carried out in Chad in 2000 and 2001 to estimate the prevalence and severity of trachoma. The main objectives were to describe the epidemiological pattern in...